Search the Newsreel

Global Corn Group shifts from debt restructuring to winding up key subsidiary to tackle audit disclaimer

Insider Spends US$192k Buying More Shares In Orion Group Holdings

An insider at Orion Group Holdings recently purchased US$192k worth of additional shares, increasing their stake to 1.3%. This transaction follows significant insider buying over the last year, suggesting confidence from those closest to the company, despite the stock price seeing a 20% decline. …

Orion Group Holdings, Inc. $ORN Stock Position Lifted by Sei Investments Co.

Sei Investments Co. significantly increased its stake in Orion Group Holdings, Inc. ($ORN) by 102.8% in the first quarter, now owning 386,663 shares valued at $4.2 million. Despite mixed analyst ratings and recent quarterly results falling short of expectations, institutional investors collectively hold 70.25% …

Stifel Nicolaus Sticks to Their Buy Rating for TXO Energy Partners LP (TXO)

Stifel Nicolaus analyst Selman Akyol has maintained a Buy rating on TXO Energy Partners LP (TXO) with a price target of $19.00. The company reported strong Q2 2026 earnings, with revenue of $150.87 million and a net profit of $60.77 million, significantly up from …

Foghorn Therapeutics Inc. 2026: Revenue $16.07M, EPS ($0.1) — 10-Q Summary

Foghorn Therapeutics Inc. reported its 2026 quarterly results, showing a significant increase in revenue to $16.07M and a narrowed net loss of ($7.19M), leading to a diluted loss per share of ($0.1). The improved financial performance was largely driven by a collaboration with Lilly …

Orion Group Holdings' (NYSE:ORN) Shareholders Have More To Worry About Than Only Soft Earnings

Orion Group Holdings (NYSE:ORN) recently reported earnings that disappointed investors, but a deeper look suggests the situation might be better than it appears. The company's statutory profit was reduced by US$3.5m due to unusual, likely one-off, items. Additionally, Orion Group Holdings received a US$5.9m …

California Resources (CRC) Could Be 33% Below Fair Value Following Carbon Storage Narrative

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. California Resources (CRC) heads into its August 10 earnings release with expectations for higher revenue and year over year earnings growth, putting fresh …

Reborn Coffee CEO, Interim CFO Purchased Shares Worth Over $23B

Lim Jung Jae, CEO and Interim CFO of Reborn Coffee (REBN), purchased 131,387 shares of the company's common stock on July 14, 2026. The purchase was made at a price of $180,000.0 per share, totaling over $23 billion. Following this transaction, Lim Jung Jae …

Capricorn Metals (ASX:CMM) Could Be 73% Undervalued Following Its Growth Update

Price to sales forward of TXO Partners, L.P. – FWB:7OJ

This article provides financial information for TXO Partners, L.P. (FWB:7OJ), specifically focusing on its price to sales forward ratio. It highlights that the market was closed at the time of viewing, with no trades occurring. The content is presented within the context of the …

Hawthorn Bancshares, Inc. (NASDAQ: HWBK) lifts Q2 earnings, eyes FSC deal

TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3

TD Cowen has reiterated its Buy rating on Pacific Biosciences of California (PACB.US) and maintained its target price at $3. This indicates a continued positive outlook from the firm regarding the company's stock performance.

HAWTHORN BANCSHARES, INC. Q2 2026: Revenue $17.3M, EPS $1.06— 10-Q Summary

Hawthorn Bancshares, Inc. reported strong second-quarter 2026 results, with net interest income reaching $17.3M and diluted EPS rising to $1.06, an increase of 20.5% year-over-year. The company's net income climbed to $7.33M, supported by an improved net interest margin and expanded non-interest revenue, including …

Owens Corning (OC) After Q2 Earnings And The Case For A Pricey Valuation

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Q2 2026 earnings event sets the stage Owens Corning (OC) is back in focus after its second quarter 2026 earnings release, which paired …

Truist Financial Issues Positive Forecast for Owens Corning (NYSE:OC) Stock Price

Truist Financial has raised its price target for Owens Corning (NYSE:OC) to $140 from $125 but maintained a "hold" rating, suggesting a potential downside despite a positive earnings report where the company surpassed EPS and revenue estimates. Other analysts have more optimistic ratings, with …

Four Corners Property Trust buys five urgent care sites

Four Corners Property Trust (FCPT) has acquired five Novant Health Urgent Care properties for $11.7 million. These properties are located in South Carolina retail corridors and operate under net leases with approximately five years remaining. The transaction was priced at a 6.9% capitalization rate, …

UBS Adjusts Price Target on Owens Corning to $198 From $174, Maintains Buy Rating

UBS has increased its price target for Owens Corning (NYSE:OC) to $198 from $174, while reiterating a Buy rating on the stock. This update comes after Owens Corning reported its Q2 2026 earnings, which showed a rise in sales and adjusted EPS that surpassed …

Press Release: FCPT Announces Acquisition of Five Novant Health Urgent Care Properties for $11.7 Million

FCPT announced the acquisition of five Novant Health Urgent Care properties for a total of $11.7 million. These properties are triple-net leased to Novant Health, a large integrated network of hospitals and clinics in the Southeast. The acquisition was funded with proceeds from FCPT's …

Reminder - California Water Service Group (CWT) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 8/10/26, California Water Service Group (Symbol: CWT) will trade ex-dividend, for its quarterly dividend of $0.335, payable on 8/21/26. As a percentage of CWT's recent stock price of $49.80, this dividend works …

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) reported a Q2 loss of $0.1 per share, outperforming the Zacks Consensus Estimate of a $0.23 loss, and significantly beat revenue estimates with $16.07 million against an expected $8.12 million. Despite this, the company's shares have declined by 9.6% year-to-date, …

Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update

Foghorn Therapeutics (Nasdaq: FHTX) released its second-quarter 2026 financial and corporate update, highlighting the advancement of its FHD-909 Phase 1 trial for NSCLC and its wholly-owned pipeline including selective EP300 and CBP degraders. The company also announced a novel oral small molecule in immunology …

Pacific Biosciences of California Q2 Earnings Call Highlights

Pacific Biosciences of California (PACB) reported Q2 2026 revenue of $39 million, largely flat year-over-year, and announced a leadership change with Mark Van Oene succeeding Christian Henry as CEO. The company lowered its full-year revenue outlook due to slower rollout of new sequencing chemistry …

TXO Partners (NYSE:TXO) Upgraded to "Hold" at Zacks Research

Zacks Research has upgraded TXO Partners (NYSE:TXO) from "Strong Sell" to "Hold" due to strong financial performance, including beating quarterly EPS and revenue estimates. The company also saw significant insider buying, with director Bob R. Simpson purchasing 500,000 shares. Despite varied analyst ratings, the …

The Bull Case For Banc of California (BANC) Could Change Following Q2 Loss And Surge In Charge-Offs

Banc of California (BANC) reported a significant net loss of US$241.35 million in Q2 2026, a stark reversal from the previous year's net income, alongside a sharp increase in net charge-offs to US$160.28 million. This deterioration in credit costs challenges the bank's investment narrative, …

Vornado Realty Trust (NYSE:VNO) Given New $44.00 Price Target at Piper Sandler

Piper Sandler has increased its price target for Vornado Realty Trust (NYSE:VNO) to $44.00 from $42.00, maintaining a "neutral" rating, which suggests a 9.1% upside. Despite this, the stock fell 1.4% to $40.32 after reporting quarterly EPS of $0.08, significantly missing the consensus estimate …

Ladenburg Thalmann Maintains Vornado Realty Trust(VNO.US) With Buy Rating, Raises Target Price to $50

Ladenburg Thalmann has reiterated its Buy rating for Vornado Realty Trust (VNO.US) and increased the price target to $50. This adjustment reflects the firm's continued confidence in the real estate company's performance and future prospects. Investors will likely view this updated rating and target …

Foghorn’s lung cancer trial advances; IND targeted for 2027

Foghorn Therapeutics reported Q2 2026 collaboration revenue of $16.1 million and narrowed its net loss to $7.2 million, supported by decreased R&D and G&A expenses. The company's FHD-909 lung cancer trial is progressing, with IND filings targeted for 2027 for a selective EP300 degrader …

Why Investor Returns Don’t Always Match Fund Performance

Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built for investors. Even the best dogs* may be tempted to chase a squirrel in the park. So may be the case with investors and returns. That's …

A Quick Look at Today's Ratings for Vornado Realty Trust(VNO.US), With a Forecast Between $32 to $45

This article provides a quick overview of analyst ratings for Vornado Realty Trust (VNO.US), noting a forecast price range between $32 and $45. The information is presented without further details in this particular content.

Lilly deal lifts Foghorn Therapeutics (Nasdaq: FHTX) Q2 2026 revenue and cuts loss

Foghorn Therapeutics (FHTX) reported significantly narrowed net losses and increased collaboration revenue in Q2 2026, primarily due to a $14.2 million cumulative catch-up adjustment from its Eli Lilly collaboration. The company's net loss decreased to $7.2 million from $17.9 million year-over-year, and revenue rose …

AI Risks and Resilient Stocks: Morningstar’s EMEA CIO on the Global Market Outlook

Morningstar's EMEA CIO, Mike Coop, discusses the current global market outlook, highlighting the unexpected resilience of equity markets despite geopolitical uncertainties and AI jitters. He emphasizes the importance of diversification given the concentration in AI and mega-cap tech stocks, suggesting opportunities in undervalued sectors …

Vornado Realty Trust $VNO Shares Bought by Quantinno Capital Management LP

ETFs Investing in Pacific Biosciences of California, Inc. Stocks

This article lists various ETFs that include Pacific Biosciences of California, Inc. (PACB) stocks in their holdings. It provides a detailed table for each ETF, including market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, …

Foghorn Therapeutics (NASDAQ:FHTX) Issues Earnings Results, Beats Estimates By $0.13 EPS

Owens Corning (OC) Stock Rallies On 24% Margin As Valuation Questions Linger

Pacific Biosciences: It's Only Getting Worse (NASDAQ:PACB)

Pacific Biosciences reported disappointing Q2 revenues of $39.01 million, missing estimates and lowering its 2026 revenue guidance below consensus. The company continues to face sizable operating and net losses, with cash reserves dwindling and significant debt outstanding. Despite trading at a steep discount to …